Apo-Megestrol

Apo-Megestrol

megestrol

Manufacturer:

Apotex

Distributor:

Pharmaforte
Concise Prescribing Info
Contents
Megestrol acetate
Indications/Uses
Adjunctive or palliative treatment of recurrent, inoperable or metastatic carcinoma of the breast & endometrium & for palliative treatment of hormone responsive advanced carcinoma of the prostate.
Dosage/Direction for Use
Palliative or adjunctive treatment of breast carcinoma 160 mg or 125 mg/m2 daily. Endometrial carcinoma 80-320 mg or 62.5-250 mg/m2 daily in divided doses. Palliative treatment of hormone responsive advanced (Stage D2) carcinoma of the prostate 120 mg as a single daily dose in combination w/ diethylstilbestrol tab 0.1 mg.
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Do not use as a diagnostic test for pregnancy.
Special Precautions
Adverse Reactions
Gynaecomastia, carpal tunnel syndrome, deep vein thrombophlebitis, alopecia, loss of hearing, hyperglycaemia, pulmonary embolism & dyspnea, wt gain, vag bleeding.
MIMS Class
Cancer Hormone Therapy
ATC Classification
L02AB01 - megestrol ; Belongs to the class of progestogens.
Presentation/Packing
Form
Apo-Megestrol tab 160 mg
Packing/Price
100's
Form
Apo-Megestrol tab 40 mg
Packing/Price
100's
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $139 a year.
Sign up for free
Already a member? Sign in